EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Azetidines in medicinal chemistry: emerging applications and approved drugs

Subba Rao Cheekatla iD

Future Medicinal Chemistry · 2026-02 · 18 (3) · 303-337

DOI: 10.1080/17568919.2025.2610169 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, online erschienen am 05.01.2026. Verfasst von Subba Rao Cheekatla. Beteiligte Einrichtung: Department of Pharmacology, Korea University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Azetidines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 414 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Azetidines are four-membered nitrogen-containing heterocycles that have emerged as vital motifs in drug discovery and medicinal chemistry due to their unique physicochemical and pharmacokinetic profiles. Owing to their distinctive structural features such as high ring strain, sp3-rich character, and conformational rigidity, which confer enhanced pharmacokinetic properties, solubility, metabolic stability and make them highly attractive scaffolds for the design of bioactive molecules. Natural and synthetic azetidine derivatives demonstrate broad pharmacological potential, ranging from muscarinic antagonists and central nervous system (CNS) modulators to potent antibacterial and anticancer agents. Additionally, significant progress in green and stereoselective synthesis such as visible-light-mediated cycloadditions, strain-release methodologies, and biocatalytic routes have enhanced their accessibility and medicinal relevance. Synthetic derivatives like PF-3635659 (M3 antagonist) and azetidine-modified nicotine analogs highlight the scaffold's utility in neurodegenerative and inflammatory disease therapeutics. Azetidine-based ligands also serve as efficient auxiliaries in asymmetric catalysis and late-stage drug functionalization. Specifically, several Food and Drug Administration (FDA)-approved drugs, such as baricitinib, cobimetinib, sarolaner, and azelnidipine, incorporate azetidine motifs to enhance metabolic stability, receptor selectivity, and pharmacokinetics. Recently, in vitro and in vivo evaluations have further highlighted their therapeutic promise across oncology, infectious diseases, and inflammation. With their growing impact on drug development and chemical biology, azetidines represent a dynamic frontier for next-generation pharmaceutical innovation and real-world therapeutic success.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzetidinesHumansChemistry, PharmaceuticalAntineoplastic AgentsAnimalsDrug DiscoveryDrug Approval

Stichwörter der Autor:innen

Azetidinebaricitinibdrug discoveryfood and drug administrationheterocyclesin vitro and in vivopharmaceuticalsring strain

Substanzen

AzetidinesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Korea University College of Medicine, Seoul, South Korea.

ORCID-Profile: Subba Rao Cheekatla

Zitieren

APA

Cheekatla, S. R. (2026). Azetidines in medicinal chemistry: emerging applications and approved drugs. Future Medicinal Chemistry, 18(3), 303-337. https://doi.org/10.1080/17568919.2025.2610169

Vancouver

Cheekatla SR. Azetidines in medicinal chemistry: emerging applications and approved drugs. Future Medicinal Chemistry. 2026;18(3):303-337. doi:10.1080/17568919.2025.2610169

BibTeX
@article{Cheekatla2026,
  author = {Cheekatla, Subba Rao},
  title = {Azetidines in medicinal chemistry: emerging applications and approved drugs},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {303--337},
  doi = {10.1080/17568919.2025.2610169}
}
Kostenlos starten →